Neimeth International Pharmaceuticals PLC 2024 Annual Report
The report highlights Neimeth International Pharmaceuticals Plc's financial and operational performance for the fiscal year 2024. The company achieved a significant turnaround with revenue growing by 103% to N4.5 billion, reversing a previous operating loss to record an operating profit of N18.9 million. Despite macroeconomic challenges, including high inflation and foreign exchange volatility, Neimeth focused on cost containment, reducing marketing and administrative expenses. The company also upgraded its production facility in Oregun, Lagos, and continued work on its new WHO-compliant factory in Anambra State to expand manufacturing capacity and support long-term growth.
Company: Neimeth International Pharmaceuticals PLC
Sector: Manufacturing
Country: Nigeria
Year: 2024
Type: Annual Report
Pages: 128
Back to company
Neimeth International Pharmaceuticals PLC
Annual Report And Accounts
The report highlights Neimeth International Pharmaceuticals Plc's financial and operational performance for the fiscal year 2024. The company achieved a significant turnaround with revenue growing by 103% to N4.5 billion, reversing a previous operating loss to record an operating profit of N18.9 million. Despite macroeconomic challenges, including high inflation and foreign exchange volatility, Neimeth focused on cost containment, reducing marketing and administrative expenses. The company also upgraded its production facility in Oregun, Lagos, and continued work on its new WHO-compliant factory in Anambra State to expand manufacturing capacity and support long-term growth.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report
Language
English
Pages
File Size
Standards & Assurance
No data available
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees